Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • CCHIO 2024 | Dr. Chunxia Su: Comprehensive Management and Research Design of IITs in Lung Cancer

    Investigator-initiated trials (IITs) refer to clinical research initiated by investigators, conducted in healthcare institutions, and aimed at studying disease diagnosis, treatment, rehabilitation, prognosis, etiology, prevention, and health maintenance. Unlike industry-sponsored trials, IITs are not intended for drug or medical device registration. In recent years, IITs have become an essential part of clinical research, providing critical…

    2024.12.11
  • CCHIO 2024 | Dr. Gang Ding: The Era of “Integration” — Exploring Tumor Rehabilitation and Health Education for a China-Specific Oncology Prevention

    The 2024 Chinese Congress on Holistic Integrative Oncology (CCHIO) concluded successfully on November 17. Following the strategic framework of “collaborative integration” in disciplinary development, the conference established dedicated sessions on tumor rehabilitation, health education, cancer prevention, and screening. These sessions offered comprehensive and multidimensional insights into new perspectives, technologies, and concepts for the full-cycle management…

    2024.12.11
  • CCHIO 2024 | Dr. Xinping Cao: Advances in Systemic Therapy for Cervical Cancer

    At the 2024 Chinese Congress on Holistic Integrative Oncology (CCHIO), Dr. Xinping Cao from Sun Yat-sen University Cancer Center presented a comprehensive lecture titled “Advances in Systemic Therapy for Cervical Cancer.” Below is a summary of the key highlights.

    2024.12.11
  • Dr. Zhaochong Zeng: Advancing Liver Cancer Care with Targeted Radiotherapy Strategies and Dual MDT Approaches

    China bears a significant burden of liver cancer. To prevent its onset and progression, the country, society, and countless physicians have undertaken extensive measures under the framework of “three-level prevention,” achieving remarkable progress. With the increasing proportion of early diagnosis and treatment of liver cancer in recent years, a key focus for radiotherapy specialists has…

    2024.12.11
  • CCHIO 2024 | Dr. Hong Liu: New Perspectives on Breast Cancer Rehabilitation – The Importance of Psychological Well-being and Multidisciplinary

    Breast cancer not only threatens patients’ lives but also imposes a heavy psychological burden on women. As the number of breast cancer cases continues to rise, its rehabilitation is gaining increasing attention from society. How to effectively promote comprehensive recovery for breast cancer patients has become an important issue in the medical field. During the…

    2024.12.11
  • The 66th American Society of Hematology (ASH) Annual Meeting was grandly held in San Diego, USA, from December 7th to 10th, 2024

    The 66th American Society of Hematology (ASH) Annual Meeting was grandly held in San Diego, USA, from December 7th to 10th, 2024. As one of the most influential platforms for scientific communication in hematology, this global event attracted over 25,000 professionals, including clinicians, researchers, and healthcare leaders from more than 100 countries. The conference covered…

    2024.12.10
  • Dr. Hua You: Development and Validation of an OS Prediction Model for HIV-Infected Liver Cancer Patients

    Individuals living with HIV are at a higher risk of developing hepatocellular carcinoma (HCC) due to immune system impairment and often face poorer prognoses. At the ongoing 2024 IDWeek Conference, Dr. Hua You from the Children’s Hospital of Chongqing Medical University presented a groundbreaking study on the development of the first-ever prognostic model tailored for…

    2024.12.10
  • AASLD 2024丨Dr. Jun Chen: Advances in Diagnosis and Prognosis of MAFLD

    Study 1: MASEF Scoring System for High-Risk MASH Diagnosis High-risk MASH, defined as NAFLD activity score (NAS) ≥ 4 and fibrosis stage ≥ 2, is associated with increased liver-related mortality.…

    2024.12.10
«previous next»
Recent Posts
  • ESMO Preview | Professor Huihui Li: Iza-bren Ushers in a New Era of Bispecific Antibody–Drug Conjugate Therapy for Breast Cancer
  • ESMO Preview | Professor Fan Wu: From Breakthrough to Transformation—How Iza-bren Is Reshaping Breast Cancer Treatment and Ushering in a New Era of Bispecific ADC Therapy
  • ESMO Preview | Professor Jiong Wu: China-Originated Innovation Goes Global—Izalontamab Brengitecan Ushers in a New Era of Bispecific ADC Therapy for Breast Cancer
  • 2026 Xianghu Breast Cancer Treatment Frontiers Conference | Professor Zhanhong Chen: Cardio-Oncology Supports Comprehensive Breast Cancer Care, While ADCs Reshape Treatment for Advanced HER2-Positive Disease
  • 2026 Xianghu Breast Cancer Treatment Frontiers Conference | Professor Hai Hu: Advancing Precision Medicine and Exploring New Approaches to Breast Cancer Care
Recent Comments
    Archives
    • October 2026
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top